Physician profile
Minon Mitchell
NPI 1295875243
$7,506.38
in general payments reported to CMS, 2019-2025
15 companies · $894 in 2025
The $894 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,365 · 2020: $546 · 2021: $2,205 · 2022: $542 · 2023: $381 · 2024: $573 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,822 · Gift: $27.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,821.54 |
| Gift | $27.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,245.53 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $2,208.67 | 2019-2025 | Acuvue |
| Coopervision INC. | $864.50 | 2019-2025 | Misight Contact Lens, Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $503.11 | 2022-2025 | Infuse, Infuse Multifocal, Vyzulta |
| The Walman Optical Company | $480.00 | 2020 | |
| Alcon Vision LLC | $272.73 | 2019-2025 | Precision7, Rhopressa, Total30 |
| Kala Pharmaceuticals, INC. | $244.64 | 2021 | |
| Sun Pharmaceutical Industries INC. | $199.91 | 2021-2025 | Cequa |
| Glaukos Corporation | $171.00 | 2021-2022 | |
| Rxsight INC | $135.59 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Eyevance Pharmaceuticals LLC | $62.01 | 2019 | |
| Allergan, INC. | $48.19 | 2022 | |
| Optos, INC. | $35.90 | 2019 | |
| Abbvie INC. | $19.83 | 2023 | |
| Novartis Pharmaceuticals Corporation | $14.77 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Minon Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.